International Stem Cell Corporation Completes A Share Exchange With BTHC III, Inc., Closes $11.2 Million Private Placement

OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation “ISC” (www.intlstemcell.com), a California-based early-stage stem cell therapeutics company, announced today that it has completed a share exchange with BTHC III, Inc. (OTCBB:BTHC). Immediately preceding the consummation of the share exchange transaction, ISC closed a private placement of its capital stock whereby it received approximately $11.2 million in gross offering proceeds, before payment of commissions and fees.